(ATN) BETA: New Treatment Newsletter Available; First Issue, AZT

DonateNow
Print this article

(ATN) BETA: New Treatment Newsletter Available; First Issue, AZT

AIDS TREATMENT NEWS No. 058 - June 3, 1988
John S. James


The first issue of the Bulletin of Experimental Treatments for AIDS (BETA), published by the San Francisco AIDS Foundation, is now in press and will be available soon. Copies can be ordered now (see below).

BETA "is published as an educational resource for people considering experimental treatments for AIDS, ARC and HIV infection". It "reviews available scientific data on AIDS treatments as well as anecdotal information provided by physicians, researchers, people with AIDS and ARC, and individuals infected with HIV". Publication by BETA of information about a treatment does not, of course, imply endorsement of that treatment by the San Francisco AIDS Foundation.

The first issue, on AZT, gives a readable, comprehensive overview on the use of the drug--including areas of controversy where physicians disagree. About five thousands words in length, the article includes:

* Dosage, toxicity, and side effects; * Combining AZT with other drugs; * AZT use by asymptomatic seropositives--pro and con; * Experiences of people taking AZT; * Physicians' comments; * A glossary; and * A resource guide to experimental treatment information.

Each issue of BETA gets a careful medical review by the Scientific Review Committee of the San Francisco AIDS Foundation.

For a copy of BETA issue #1, call the San Francisco AIDS Foundation, (415) 863-AIDS; or in Northern California call toll-free (800) FOR-AIDS. It's free in San Francisco.


880603
ATN05805


Copyright © 1988 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org  http://www.aidsnews.org

Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .